AxoGen (AXGN) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.80 | -0.79 | -2.87 | 5.79 | 167.1 | -10.9 | |||
| Changes by years, y/y, % | -69% | -200% | +262% | -302% | +2 785% | +130.6% | |||
AxoGen. Debt/EBITDA
AxoGen. Debt/EBITDA, changes, %
AxoGen (AXGN) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 5.28 | 2.98 | 1.49 | 3.64 | 7.53 | -10.9 | ||
| Changes by years, y/y, % | -202% | -113% | -94% | -37% | +43% | |||
| Changes by quarters, q/q, % | -9% | -44% | -50% | +143% | +107% | |||